Field & Main Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Field & Main Bank's ELV Position: Q1 2026 in Review
Field & Main Bank reduced its Elevance Health (ELV) stake by 3.9% in Q1 2026, selling an estimated $25K and leaving 1,858 shares worth $544K. The position accounts for 0.16% of the portfolio, ranked #99.
Field & Main Bank first reported a position in ELV in Q3 2019 and has held it in 26 quarters since. The position peaked at $678K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Field & Main Bank held 1,858 shares of Elevance Health worth $544K as of Q1 2026.
- Field & Main Bank sold 76 Elevance Health shares in Q1 2026, an estimated $25K.
- Elevance Health made up 0.16% of Field & Main Bank's portfolio in Q1 2026, its #99 holding.
- Field & Main Bank first reported a position in Elevance Health in Q3 2019 and has held it in 26 quarters since.
- Field & Main Bank's Elevance Health position peaked at $678K in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.